Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants

Journal of the Formosan Medical Association

Volumn 106, Issue 2, 2007, Pages 148-155

  Chen, Chien Hung ^a   Yang, Pei Ming ^a   Huang, Guan Tarn ^a   Lee, Hsuan Shu ^a   Sung, Juei Low ^b,c   Sheu, Jin Chuan ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Sun Yat Sen Hospital 125   (Taiwan)

^c Liver Disease Prevention and Treatment Research Foundation   (Taiwan)

Author keywords

Geographic variation; Hepatitis B virus; Hepatitis C virus; Screening; Seroprevalence; Taiwan

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY SCREENING; ARTICLE; BLOOD SAMPLING; COMMUNITY CARE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER DISEASE; MALE; MASS SCREENING; SEROPREVALENCE; TAIWAN; VIRUS CARRIER;

EID: 33847768257     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60231-X     Document Type: Article

References (24)

1. Chen DS, Kuo GC, Sung JL, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990;162:817-22.
2. Department of Health Taiwan. Cause of Death Statistics. Available at: http://www.doh.gov.tw [Date accessed: May 2005]
3. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-308.
4. Chen DS. Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo: Springer-Verlag, 1987:71-80.
5. Chang MH. Natural history of hepatitis B virus infection in children. J Gastroenterol Hepatol 2000;15(Suppl):E16-9.
6. Hsu HY, Chang MH, Chen DS, et al. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301-7.
7. Stevens CE, Beasley RP, Tsui J, et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292:771-4.
8. Chen DS, Hsu NH, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597-603.
9. Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800.
10. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9.
11. Lee SD, Chan CY, Wang YJ, et al. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 1991;13:830-3.
12. Wang JT, Wang TH, Sheu JC, et al. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Arch Pathol Lab Med 1993;117:152-6.
13. Sheu JC, Wang JT, Wang TH, et al. Prevalence of hepatitis C viral infection in a community in Taiwan. Detection by synthetic peptide-based assay and polymerase chain reaction. J Hepatol 1993;17:192-8.
14. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 1999;59:290-6.
15. Wang JH, Lu SN, Wu JC, et al. A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan. Trans R Soc Trop Med Hyg 1999;93:253-4.
16. Lu SN, Chue PY, Chen HC, et al. Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan. J Gastroenterol Hepatol 1997;12:547-50.
17. Wu JS, Lu CF, Chou WH, et al. High prevalence of hepatitis C virus infection in aborigines in Taiwan. Jpn J Med Sci Biol 1992;45:165-74.
18. Lin CC, Hwang SJ, Chiou ST, et al. The prevalence and risk factor analysis of serum antibody to hepatitis C virus in the elderly in northeast Taiwan. J Chin Med Assoc 2003;66: 103-8.
19. Lin HH, Li YH, Yu JH, et al. Ethnic and geographic variations in the prevalence of hepatitis A, B and C among aboriginal villages in Hualien, Taiwan. Infection 2000;28:205-8.
20. Department of Statistics of the Ministry of the Interior. Available at: http://www.moi.gov.tw/stat/index.asp. [Date accessed: June 2005]
21. Lee CM, Lu SN, Changchien CS, et al. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 1999;86:1143-50.
22. Sun CA, Chen HC, Lu SN, et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 2001;65:30-4.
23. Huo TI, Wu JC, Lee PC, et al. Seroclearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998;28:231-6.
24. Chen YC, Sheen IS, Chu CM, et al. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002;123:1084-9.